Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
A substrate binding hinge domain is critical for transport-related structural changes of organic cation transporter 1.
Egenberger B
,
Gorboulev V
,
Keller T
,
Gorbunov D
,
Gottlieb N
,
Geiger D
,
Mueller TD
,
Koepsell H
.
???displayArticle.abstract???
Organic cation transporters are membrane potential-dependent facilitative diffusion systems. Functional studies, extensive mutagenesis, and homology modeling indicate the following mechanism. A transporter conformation with a large outward-open cleft binds extracellular substrate, passes a state in which the substrate is occluded, turns to a conformation with an inward-open cleft, releases substrate, and subsequently turns back to the outward-open state. In the rat organic cation transporter (rOct1), voltage- and ligand-dependent movements of fluorescence-labeled cysteines were measured by voltage clamp fluorometry. For fluorescence detection, cysteine residues were introduced in extracellular parts of cleft-forming transmembrane α-helices (TMHs) 5, 8, and 11. Following expression of the mutants in Xenopus laevis oocytes, cysteines were labeled with tetramethylrhodamine-6-maleimide, and voltage-dependent conformational changes were monitored by voltage clamp fluorometry. One cysteine was introduced in the central domain of TMH 11 replacing glycine 478. This domain contains two amino acids that are involved in substrate binding and two glycine residues (Gly-477 and Gly-478) allowing for helix bending. Cys-478 could be modified with the transported substrate analog [2-(trimethylammonium)-ethyl]methanethiosulfonate but was inaccessible to tetramethylrhodamine-6-maleimide. Voltage-dependent movements at the indicator positions of TMHs 5, 8, and 11 were altered by substrate applications indicating large conformational changes during transport. The G478C exchange decreased transporter turnover and blocked voltage-dependent movements of TMHs 5 and 11. [2-(Trimethylammonium)-ethyl]methanethiosulfonate modification of Cys-478 blocked substrate binding, transport activity, and movement of TMH 8. The data suggest that Gly-478 is located within a mechanistically important hinge domain of TMH 11 in which substrate binding induces transport-related structural changes.
Budiman,
Mechanism of electrogenic cation transport by the cloned organic cation transporter 2 from rat.
2000, Pubmed
Budiman,
Mechanism of electrogenic cation transport by the cloned organic cation transporter 2 from rat.
2000,
Pubmed
Busch,
Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1.
1996,
Pubmed
,
Xenbase
Busch,
Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine.
1998,
Pubmed
,
Xenbase
Ciarimboli,
Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation.
2005,
Pubmed
Geibel,
Conformational dynamics of Na+/K+- and H+/K+-ATPase probed by voltage clamp fluorometry.
2003,
Pubmed
,
Xenbase
Gorboulev,
Selectivity of the polyspecific cation transporter rOCT1 is changed by mutation of aspartate 475 to glutamate.
1999,
Pubmed
,
Xenbase
Gorbunov,
High-affinity cation binding to organic cation transporter 1 induces movement of helix 11 and blocks transport after mutations in a modeled interaction domain between two helices.
2008,
Pubmed
Gründemann,
Ethidium bromide staining during denaturation with glyoxal for sensitive detection of RNA in agarose gel electrophoresis.
1994,
Pubmed
Ho,
Site-directed mutagenesis by overlap extension using the polymerase chain reaction.
1989,
Pubmed
Kamsteeg,
Detection of aquaporin-2 in the plasma membranes of oocytes: a novel isolation method with improved yield and purity.
2001,
Pubmed
,
Xenbase
Kanner,
Molecular physiology: intimate contact enables transport.
2005,
Pubmed
Keller,
Cell free expression and functional reconstitution of eukaryotic drug transporters.
2008,
Pubmed
Keller,
The large extracellular loop of organic cation transporter 1 influences substrate affinity and is pivotal for oligomerization.
2011,
Pubmed
,
Xenbase
Koepsell,
Molecular pharmacology of organic cation transporters in kidney.
1999,
Pubmed
Koepsell,
Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications.
2007,
Pubmed
Koepsell,
Substrate recognition and translocation by polyspecific organic cation transporters.
2011,
Pubmed
Minuesa,
Transport of lamivudine [(-)-beta-L-2',3'-dideoxy-3'-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3.
2009,
Pubmed
Nies,
Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.
2011,
Pubmed
Pace,
A helix propensity scale based on experimental studies of peptides and proteins.
1998,
Pubmed
Pelis,
Functional significance of conserved cysteines in the human organic cation transporter 2.
2012,
Pubmed
Perry,
A three-dimensional model of human organic anion transporter 1: aromatic amino acids required for substrate transport.
2006,
Pubmed
,
Xenbase
Popp,
Amino acids critical for substrate affinity of rat organic cation transporter 1 line the substrate binding region in a model derived from the tertiary structure of lactose permease.
2005,
Pubmed
,
Xenbase
Rosental,
A conserved methionine residue controls the substrate selectivity of a neuronal glutamate transporter.
2010,
Pubmed
,
Xenbase
Schmitt,
Alkali cation binding and permeation in the rat organic cation transporter rOCT2.
2005,
Pubmed
,
Xenbase
Schmitt,
Charge-to-substrate ratio during organic cation uptake by rat OCT2 is voltage dependent and altered by exchange of glutamate 448 with glutamine.
2009,
Pubmed
,
Xenbase
Schmitt,
An improved method for real-time monitoring of membrane capacitance in Xenopus laevis oocytes.
2002,
Pubmed
,
Xenbase
Screpanti,
Discontinuous membrane helices in transport proteins and their correlation with function.
2007,
Pubmed
Shu,
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.
2007,
Pubmed
Sturm,
Identification of cysteines in rat organic cation transporters rOCT1 (C322, C451) and rOCT2 (C451) critical for transport activity and substrate affinity.
2007,
Pubmed
,
Xenbase
Valentin,
The transport modifier RS1 is localized at the inner side of the plasma membrane and changes membrane capacitance.
2000,
Pubmed
,
Xenbase
Vernaleken,
Tripeptides of RS1 (RSC1A1) inhibit a monosaccharide-dependent exocytotic pathway of Na+-D-glucose cotransporter SGLT1 with high affinity.
2007,
Pubmed
,
Xenbase
Veyhl,
Cloning of a membrane-associated protein which modifies activity and properties of the Na(+)-D-glucose cotransporter.
1993,
Pubmed
,
Xenbase
Volk,
Five amino acids in the innermost cavity of the substrate binding cleft of organic cation transporter 1 interact with extracellular and intracellular corticosterone.
2009,
Pubmed
,
Xenbase
Volk,
Different affinities of inhibitors to the outwardly and inwardly directed substrate binding site of organic cation transporter 2.
2003,
Pubmed
,
Xenbase
Zhang,
A conserved glutamate residue in transmembrane helix 10 influences substrate specificity of rabbit OCT2 (SLC22A2).
2005,
Pubmed
